Vaccine Approval Could Mark a Turning Point in CRE Price Discovery

National Real Estate Investor, Dec 15, 2020–Beth Mattson-Teig
Investors hoping to cash in on a COVID-19 pricing discounts may see opportunities slip away as emergency-use approval of the first vaccine against in the virus was granted to Pfizer and with availability expected to grow as other firms gain approvals in the coming weeks and months